NatWest Group’s Bio-Techne TECH Stock Holding History

NatWest Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-29,392	Closed	-$679K	–	307
2015 Q3	$679K	Buy	+29,392	New	+$737K	0.02%	235
2015 Q2	–	Sell	-29,392	Closed	-$737K	–	424
2015 Q1	$737K	Buy	29,392 +3,712	+14%	+$88.3K	0.01%	266
2014 Q4	$593K	Sell	25,680 -70,052	-73%	-$1.6M	0.01%	290
2014 Q3	$2.24M	Buy	95,732 +47,336	+98%	+$1.11M	0.02%	181
2014 Q2	$1.12M	Sell	48,396 -2,372	-5%	-$52.4K	0.05%	250
2014 Q1	$1.08M	Buy	50,768 +112	+0.2%	+$2.52K	0.05%	234
2013 Q4	$1.2M	Buy	50,656 +32,044	+172%	+$694K	0.03%	384
2013 Q3	$373K	Buy	+18,612	New	+$353K	0.01%	812

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

NatWest Group's TECH Position: Q4 2015 in Review

NatWest Group sold out of Bio-Techne (TECH) in Q4 2015, closing a stake of 29,392 shares — an estimated $679K sold.

NatWest Group first reported a position in TECH in Q3 2013 and held it in 8 quarters. The position peaked at $2.24M in Q3 2014. 260 funds tracked by Wall St. Rank hold TECH as of Q4 2015.

NatWest Group reported no remaining Bio-Techne position as of Q4 2015 after selling out during the quarter.
NatWest Group sold 29,392 Bio-Techne shares in Q4 2015, an estimated $679K.
NatWest Group first reported a position in Bio-Techne in Q3 2013 and held it in 8 quarters.
NatWest Group's Bio-Techne position peaked at $2.24M in Q3 2014.
260 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.